Preferred continuous glucose monitors (CGMs) FreeStyle Libre 2, FreeStyle Libre 3, Dexcom G6, and Dexcom G7 are the preferred continuous glucose monitors when submitted through the pharmacy benefit manager (PBM) and are covered at a 10% cost-sharing
Approval for Cardiovascular Risk Reduction Ongoing cardiovascular outcomes trials (CVOT) studies clearly demonstrated that three of the diabetes incretin medications (liraglutide, dulaglutide and semaglutide) and one of the weight loss versions of this class (Wegovy) also reduce cardiovascular disease risk
Tape-ins offer a more semi-permanent fix, while keratin bond fusions can last even longer for those who want to set it and forget it
These effects have made them highly effective and, in many cases, revolutionary for managing metabolic health
At the same time, the pills could greatly improve access to the medication by lowering coststhe injections can cost hundreds of dollars per month out of pocket
Dont let Ozempic teeth catch you off guardbe proactive, stay informed, and maintain regular dental care
